Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

NCT02697838 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Malignant Neoplasm of Stomach Stage II

Interventions

DRUG: Apatinib
DRUG: Paclitaxel-based chemotherapeutic regimens

Sponsor

Fujian Cancer Hospital